166 related articles for article (PubMed ID: 20713527)
1. ZIC1 overexpression is oncogenic in liposarcoma.
Brill E; Gobble R; Angeles C; Lagos-Quintana M; Crago A; Laxa B; Decarolis P; Zhang L; Antonescu C; Socci ND; Taylor BS; Sander C; Koff A; Singer S
Cancer Res; 2010 Sep; 70(17):6891-901. PubMed ID: 20713527
[TBL] [Abstract][Full Text] [Related]
2. Expression profiling of liposarcoma yields a multigene predictor of patient outcome and identifies genes that contribute to liposarcomagenesis.
Gobble RM; Qin LX; Brill ER; Angeles CV; Ugras S; O'Connor RB; Moraco NH; Decarolis PL; Antonescu C; Singer S
Cancer Res; 2011 Apr; 71(7):2697-705. PubMed ID: 21335544
[TBL] [Abstract][Full Text] [Related]
3. Syndecan-1 regulates adipogenesis: new insights in dedifferentiated liposarcoma tumorigenesis.
Zaragosi LE; Dadone B; Michiels JF; Marty M; Pedeutour F; Dani C; Bianchini L
Carcinogenesis; 2015 Jan; 36(1):32-40. PubMed ID: 25344834
[TBL] [Abstract][Full Text] [Related]
4. Aberrant calreticulin expression is involved in the dedifferentiation of dedifferentiated liposarcoma.
Hisaoka M; Matsuyama A; Nakamoto M
Am J Pathol; 2012 May; 180(5):2076-83. PubMed ID: 22429966
[TBL] [Abstract][Full Text] [Related]
5. ZIC1 is silenced and has tumor suppressor function in malignant pleural mesothelioma.
Cheng YY; Kirschner MB; Cheng NC; Gattani S; Klebe S; Edelman JJ; Vallely MP; McCaughan BC; Jin HC; van Zandwijk N; Reid G
J Thorac Oncol; 2013 Oct; 8(10):1317-28. PubMed ID: 24457242
[TBL] [Abstract][Full Text] [Related]
6. Small RNA sequencing and functional characterization reveals MicroRNA-143 tumor suppressor activity in liposarcoma.
Ugras S; Brill E; Jacobsen A; Hafner M; Socci ND; Decarolis PL; Khanin R; O'Connor R; Mihailovic A; Taylor BS; Sheridan R; Gimble JM; Viale A; Crago A; Antonescu CR; Sander C; Tuschl T; Singer S
Cancer Res; 2011 Sep; 71(17):5659-69. PubMed ID: 21693658
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma.
Singer S; Socci ND; Ambrosini G; Sambol E; Decarolis P; Wu Y; O'Connor R; Maki R; Viale A; Sander C; Schwartz GK; Antonescu CR
Cancer Res; 2007 Jul; 67(14):6626-36. PubMed ID: 17638873
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome analysis identifies TODL as a novel lncRNA associated with proliferation, differentiation, and tumorigenesis in liposarcoma through FOXM1.
Kanojia D; Kirtonia A; Srujana NSV; Jeevanandan SP; Shyamsunder P; Sampath SS; Dakle P; Mayakonda A; Kaur H; Yanyi J; Koeffler HP; Garg M
Pharmacol Res; 2022 Nov; 185():106462. PubMed ID: 36167276
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression profiles distinguish liposarcoma subtypes and implicate miR-145 and miR-451 as tumor suppressors.
Gits CM; van Kuijk PF; Jonkers MB; Boersma AW; Smid M; van Ijcken WF; Coindre JM; Chibon F; Verhoef C; Mathijssen RH; den Bakker MA; Verweij J; Sleijfer S; Wiemer EA
Int J Cancer; 2014 Jul; 135(2):348-61. PubMed ID: 24375455
[TBL] [Abstract][Full Text] [Related]
10. Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma.
Zhang K; Chu K; Wu X; Gao H; Wang J; Yuan YC; Loera S; Ho K; Wang Y; Chow W; Un F; Chu P; Yen Y
Cancer Res; 2013 Feb; 73(4):1298-307. PubMed ID: 23393200
[TBL] [Abstract][Full Text] [Related]
11. Frequent alterations and epigenetic silencing of differentiation pathway genes in structurally rearranged liposarcomas.
Taylor BS; DeCarolis PL; Angeles CV; Brenet F; Schultz N; Antonescu CR; Scandura JM; Sander C; Viale AJ; Socci ND; Singer S
Cancer Discov; 2011 Dec; 1(7):587-97. PubMed ID: 22328974
[TBL] [Abstract][Full Text] [Related]
12. c-Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme.
Snyder EL; Sandstrom DJ; Law K; Fiore C; Sicinska E; Brito J; Bailey D; Fletcher JA; Loda M; Rodig SJ; Dal Cin P; Fletcher CD
J Pathol; 2009 Jul; 218(3):292-300. PubMed ID: 19449367
[TBL] [Abstract][Full Text] [Related]
13. p27(kip1) protein expression correlates with survival in myxoid and round-cell liposarcoma.
Oliveira AM; Nascimento AG; Okuno SH; Lloyd RV
J Clin Oncol; 2000 Aug; 18(15):2888-93. PubMed ID: 10920137
[TBL] [Abstract][Full Text] [Related]
14. FUS-CHOP fusion protein expression coupled to p53 deficiency induces liposarcoma in mouse but not in human adipose-derived mesenchymal stem/stromal cells.
Rodriguez R; Rubio R; Gutierrez-Aranda I; Melen GJ; Elosua C; GarcĂa-Castro J; Menendez P
Stem Cells; 2011 Feb; 29(2):179-92. PubMed ID: 21732477
[TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of NCC-DDLPS1-C1: a novel patient-derived cell line of dedifferentiated liposarcoma.
Tsuchiya R; Yoshimatsu Y; Noguchi R; Sei A; Takeshita F; Sugaya J; Fukushima S; Yoshida A; Ohtori S; Kawai A; Kondo T
Hum Cell; 2021 Jan; 34(1):260-270. PubMed ID: 32949334
[TBL] [Abstract][Full Text] [Related]
16. Managing Liposarcomas: Cutting Through the Fat.
Manji GA; Schwartz GK
J Oncol Pract; 2016 Mar; 12(3):221-7. PubMed ID: 26962163
[TBL] [Abstract][Full Text] [Related]
17. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy.
Barretina J; Taylor BS; Banerji S; Ramos AH; Lagos-Quintana M; Decarolis PL; Shah K; Socci ND; Weir BA; Ho A; Chiang DY; Reva B; Mermel CH; Getz G; Antipin Y; Beroukhim R; Major JE; Hatton C; Nicoletti R; Hanna M; Sharpe T; Fennell TJ; Cibulskis K; Onofrio RC; Saito T; Shukla N; Lau C; Nelander S; Silver SJ; Sougnez C; Viale A; Winckler W; Maki RG; Garraway LA; Lash A; Greulich H; Root DE; Sellers WR; Schwartz GK; Antonescu CR; Lander ES; Varmus HE; Ladanyi M; Sander C; Meyerson M; Singer S
Nat Genet; 2010 Aug; 42(8):715-21. PubMed ID: 20601955
[TBL] [Abstract][Full Text] [Related]
18. Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma.
Kuroda M; Ishida T; Horiuchi H; Kida N; Uozaki H; Takeuchi H; Tsuji K; Imamura T; Mori S; Machinami R
Am J Pathol; 1995 Nov; 147(5):1221-7. PubMed ID: 7485386
[TBL] [Abstract][Full Text] [Related]
19. Lipomatous tumors.
Weiss SW
Monogr Pathol; 1996; 38():207-39. PubMed ID: 8744279
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Molecular Spectrum of Liposarcoma.
Lee ATJ; Thway K; Huang PH; Jones RL
J Clin Oncol; 2018 Jan; 36(2):151-159. PubMed ID: 29220294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]